Karl W. Henry
- Molecular Biology top 10%
- Genomics and Chromatin Dynamics 6
- Fungal and yeast genetics research 5
- Ubiquitin and proteasome pathways 3
- Histone Deacetylase Inhibitors Research 2
- Cancer-related gene regulation 2
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 3
- Aging top 10%
- Pharmacology top 10%
- Fungal Biology and Applications 4
-
- Plant Molecular Biology Research 2
- Co-authors
- Shelley L. BergerThomas D. EdlindJoseph T. NickelsMary Ann OsleyAnastasia WyceN. C. Tolga EmreLorraine PillusAli Shilatifard
- Journals
- Journal of Biological Chemistry (1 paper)Genes & Development (2 papers)The EMBO Journal (1 paper)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Karl W. Henry
15 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Molecular Biology 1.2k
- Infectious Diseases 293
- Aging 20
- Pharmacology 122
- Epidemiology 208
Countries citing papers authored by Karl W. Henry
This map shows the geographic impact of Karl W. Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl W. Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl W. Henry more than expected).
Fields of papers citing papers by Karl W. Henry
This network shows the impact of papers produced by Karl W. Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl W. Henry. The network helps show where Karl W. Henry may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karl W. Henry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 80 | |
| 2 | 2005 | 76 | |
| 3 | 2005 | 133 | |
| 4 | 2005 | 31 | |
| 5 | 2004 | 179 | |
| 6 | 2004 | 18 | |
| 7 | 2003 | 17 | |
| 8 | Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8breakdown → | 2003 | 547 |
| 9 | 2002 | 96 | |
| 10 | 2002 | 49 | |
| 11 | 2002 | 41 | |
| 12 | 2001 | 24 | |
| 13 | 2001 | 48 | |
| 14 | 2000 | 174 | |
| 15 | 1999 | 43 |
About Karl W. Henry
Karl W. Henry is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases, having authored 15 papers that have together received 1.6k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (6 papers), Fungal and yeast genetics research (5 papers), Fungal Biology and Applications (4 papers), Antifungal resistance and susceptibility (3 papers), Ubiquitin and proteasome pathways (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Plant Molecular Biology Research (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Infectious Diseases (293 citations) and Aging (20 citations). Karl W. Henry has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Shelley L. Berger, Thomas D. Edlind, Joseph T. Nickels, Mary Ann Osley, Anastasia Wyce, N. C. Tolga Emre, Lorraine Pillus, Ali Shilatifard, Laura J. Duggan and Säntosh K. Katiyar. Their work appears in journals such as Journal of Biological Chemistry, Genes & Development and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.